Drug Detail
Information about BIIB028
Generic Name |
||
|---|---|---|
IND |
BIIB028 | |
Brand Name (US) |
||
Manufacturer |
Biogen Idec | |
Drug Type |
HSP90 Inhibitor | |
Delivery |
Intravenous | |
Approval Status |
Discontinued? | |
Indications |
||
Overall Strategy |
KIT Protein Based | |
Strategy |
Destroy KIT | |
Drug Category |
HSP90 inhibitor | |
BIIB028 is a HSP90 inhibitor developed by Biogen. Biogen seems to be restructuring and eliminating their oncology programs.
Links |
|
Trials of this drug |
|
|
Administration of BIIB028 to Subjects With Solid Tumors |
Trial results |
|
Search for this drug/combination in: